BASE life science A/S — Credit Rating and Financial Key Figures
CVR number: 30906942
Lyngbyvej 2, 2100 København Ø
contact@baselifescience.com
tel: 88202120
www.baselifescience.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | 110 194.51 | 158 135.50 | 202 294.94 | 236 774.34 |
| Employee benefit expenses | -89 329.66 | - 125 405.77 | - 223 849.71 | - 315 093.35 |
| Total depreciation | - 138.38 | - 914.79 | -2 900.36 | -3 784.75 |
| EBIT | 20 726.47 | 31 815.00 | -24 455.13 | -82 103.76 |
| Other financial income | 26.51 | 113.71 | 171.04 | 3 158.73 |
| Other financial expenses | - 277.90 | - 460.66 | - 722.70 | -6 849.83 |
| Pre-tax profit | 20 475.09 | 31 468.18 | -25 006.79 | -85 794.86 |
| Income taxes | -3 198.04 | -7 273.18 | -6 217.50 | -2 512.27 |
| Net earnings | 17 277.05 | 24 195.00 | -31 224.29 | -88 307.13 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Development expenditure | 4 123.26 | 4 839.42 | 3 859.75 | 2 894.81 |
| Intangible rights | 83.07 | 65.27 | ||
| Intangible assets total | 4 123.26 | 4 839.42 | 3 942.82 | 2 960.08 |
| Machinery and equipment | 470.34 | 3 097.71 | 3 999.05 | 3 118.10 |
| Tangible assets total | 470.34 | 3 097.71 | 3 999.05 | 3 118.10 |
| Other receivables | 468.92 | 925.49 | 1 051.81 | 1 689.26 |
| Investments total | 468.92 | 925.49 | 1 051.81 | 1 689.26 |
| Long term receivables total | ||||
| Inventories total | ||||
| Current trade debtors | 33 474.78 | 72 812.58 | 41 975.38 | 59 841.21 |
| Current owed by particip. interest comp. | 1 284.33 | 7 838.28 | ||
| Prepayments and accrued income | 409.69 | 4 135.83 | 2 571.55 | 4 205.23 |
| Current other receivables | 8 173.28 | 10 797.66 | 52 603.74 | 54 618.13 |
| Current deferred tax assets | 921.39 | 2 482.46 | ||
| Short term receivables total | 42 979.14 | 87 746.07 | 98 434.99 | 128 985.31 |
| Cash and bank deposits | 9 347.61 | 3 676.31 | 12 229.01 | 18 681.48 |
| Cash and cash equivalents | 9 347.61 | 3 676.31 | 12 229.01 | 18 681.48 |
| Balance sheet total (assets) | 57 389.26 | 100 285.00 | 119 657.68 | 155 434.23 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Share capital | 600.00 | 600.00 | 597.40 | 597.40 |
| Shares repurchased | 2 109.00 | |||
| Other reserves | 4 123.26 | 3 762.99 | 3 010.61 | 2 257.95 |
| Retained earnings | 4 804.80 | 21 657.01 | 49 112.51 | 18 853.17 |
| Profit of the financial year | 17 277.05 | 24 195.00 | -31 224.29 | -88 307.13 |
| Shareholders equity total | 28 914.10 | 50 215.00 | 21 496.23 | -66 598.61 |
| Provisions | 1 250.00 | 1 265.27 | 997.93 | 802.66 |
| Non-current loans from credit institutions | 1 923.29 | |||
| Non-current owed to group member | 97 379.54 | |||
| Non-current liabilities total | 1 923.29 | 97 379.54 | ||
| Current loans from credit institutions | 110.68 | 3 063.09 | 347.65 | 558.51 |
| Advances received | 256.35 | 947.68 | 2 407.56 | 7 817.50 |
| Current trade creditors | 2 041.21 | 9 027.60 | 3 895.98 | 9 372.69 |
| Current owed to participating | 513.06 | 513.06 | ||
| Current owed to group member | 1 254.01 | 7 959.78 | ||
| Short-term deferred tax liabilities | 3 451.76 | 9 089.48 | 10 468.09 | 3 147.66 |
| Other non-interest bearing current liabilities | 16 743.40 | 26 163.27 | 78 790.23 | 94 994.49 |
| Accruals and deferred income | 2 185.41 | |||
| Current liabilities total | 25 301.87 | 48 804.18 | 97 163.52 | 123 850.64 |
| Balance sheet total (liabilities) | 57 389.26 | 100 284.44 | 119 657.68 | 155 434.23 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.